Global Myasthenia Gravis Drugs Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • ID:PD038625
  • June 2019
  • GIR (Global Info Research)
                          

The Global Myasthenia Gravis Drugs Market Report is equipped with market data from 2014 to 2024. The report gives a market overview covering key drivers and risks factors. The report is bifurcated by top global manufactures mentioning sales, revenue and prices as applicable. It also evaluates the competitive scenario of the leading players. The report expands to cover regional market data along with type and application. The report forecasts sales and revenue from 2019 to 2024. The detailed sales channel is also covered in the study.

Acetylcholine esterase (AChE) inhibitors are considered to be the basic treatment of myasthenia gravis (MG). Edrophonium is primarily used as a diagnostic tool owing to its short half-life. Pyridostigmine is used for long-term maintenance.

Scope of the Report:
The market is witnessing the rapid development of novel drugs such as monoclonal antibodies, which is one of the primary factors driving this market’s growth prospects. Most drug manufacturers are increasingly focussing on the development of monoclonal antibodies, as they act specifically on target cells; thereby, leading to lower side effects. Since conventional therapies such as acetylcholinesterase inhibitor, oral steroids, and immunomodulatory agents are associated with more side effects, physicians prefer to prescribe high efficacious monoclonal antibodies.

The worldwide market for Myasthenia Gravis Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019.

This report focuses on the Myasthenia Gravis Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

  •     Flamel Technologies
  •     Roche
  •     Grifols
  •     Pfizer
  •     Shire
  •     Novartis
  •     Valeant
  •     Alexion
  •     Catalyst
  •     CSL
  •     Curavac
  •     Cytokinetics
  •     Galencia
  •     GlaxoSmithKline
  •     Lupin Pharmaceuticals
  •     Mitsubishi Tanabe Pharma

Market Segment by Regions, regional analysis covers
  •     North America (United States, Canada and Mexico)
  •     Europe (Germany, France, UK, Russia and Italy)
  •     Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
  •     South America (Brazil, Argentina, Colombia etc.)
  •     Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
  •     Anticholinesterases
  •     Immunosuppressants
  •     Intravenous Immune Globulins

Market Segment by Applications, can be divided into
  •     Hospitals
  •     Clinics

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Myasthenia Gravis Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Myasthenia Gravis Drugs, with price, sales, revenue and global market share of Myasthenia Gravis Drugs in 2017 and 2018.
Chapter 3, the Myasthenia Gravis Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Myasthenia Gravis Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Myasthenia Gravis Drugs market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Myasthenia Gravis Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Myasthenia Gravis Drugs Introduction
    1.2 Market Analysis by Type
        1.2.1 Anticholinesterases
        1.2.2 Immunosuppressants
        1.2.3 Intravenous Immune Globulins
    1.3 Market Analysis by Applications
        1.3.1 Hospitals
        1.3.2 Clinics
    1.4 Market Analysis by Regions
        1.4.1 North America (United States, Canada and Mexico)
            1.4.1.1 United States Market States and Outlook (2014-2024)
            1.4.1.2 Canada Market States and Outlook (2014-2024)
            1.4.1.3 Mexico Market States and Outlook (2014-2024)
        1.4.2 Europe (Germany, France, UK, Russia and Italy)
            1.4.2.1 Germany Market States and Outlook (2014-2024)
            1.4.2.2 France Market States and Outlook (2014-2024)
            1.4.2.3 UK Market States and Outlook (2014-2024)
            1.4.2.4 Russia Market States and Outlook (2014-2024)
            1.4.2.5 Italy Market States and Outlook (2014-2024)
        1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
            1.4.3.1 China Market States and Outlook (2014-2024)
            1.4.3.2 Japan Market States and Outlook (2014-2024)
            1.4.3.3 Korea Market States and Outlook (2014-2024)
            1.4.3.4 India Market States and Outlook (2014-2024)
            1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
        1.4.4 South America, Middle East and Africa
            1.4.4.1 Brazil Market States and Outlook (2014-2024)
            1.4.4.2 Egypt Market States and Outlook (2014-2024)
            1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
            1.4.4.4 South Africa Market States and Outlook (2014-2024)
            1.4.4.5 Turkey Market States and Outlook (2014-2024)
    1.5 Market Dynamics
        1.5.1 Market Opportunities
        1.5.2 Market Risk
        1.5.3 Market Driving Force
2 Manufacturers Profiles
    2.1 Flamel Technologies
        2.1.1 Business Overview
        2.1.2 Myasthenia Gravis Drugs Type and Applications
            2.1.2.1 Product A
            2.1.2.2 Product B
        2.1.3 Flamel Technologies Myasthenia Gravis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.2 Roche
        2.2.1 Business Overview
        2.2.2 Myasthenia Gravis Drugs Type and Applications
            2.2.2.1 Product A
            2.2.2.2 Product B
        2.2.3 Roche Myasthenia Gravis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.3 Grifols
        2.3.1 Business Overview
        2.3.2 Myasthenia Gravis Drugs Type and Applications
            2.3.2.1 Product A
            2.3.2.2 Product B
        2.3.3 Grifols Myasthenia Gravis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.4 Pfizer
        2.4.1 Business Overview
        2.4.2 Myasthenia Gravis Drugs Type and Applications
            2.4.2.1 Product A
            2.4.2.2 Product B
        2.4.3 Pfizer Myasthenia Gravis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.5 Shire
        2.5.1 Business Overview
        2.5.2 Myasthenia Gravis Drugs Type and Applications
            2.5.2.1 Product A
            2.5.2.2 Product B
        2.5.3 Shire Myasthenia Gravis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.6 Novartis
        2.6.1 Business Overview
        2.6.2 Myasthenia Gravis Drugs Type and Applications
            2.6.2.1 Product A
            2.6.2.2 Product B
        2.6.3 Novartis Myasthenia Gravis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.7 Valeant
        2.7.1 Business Overview
        2.7.2 Myasthenia Gravis Drugs Type and Applications
            2.7.2.1 Product A
            2.7.2.2 Product B
        2.7.3 Valeant Myasthenia Gravis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.8 Alexion
        2.8.1 Business Overview
        2.8.2 Myasthenia Gravis Drugs Type and Applications
            2.8.2.1 Product A
            2.8.2.2 Product B
        2.8.3 Alexion Myasthenia Gravis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.9 Catalyst
        2.9.1 Business Overview
        2.9.2 Myasthenia Gravis Drugs Type and Applications
            2.9.2.1 Product A
            2.9.2.2 Product B
        2.9.3 Catalyst Myasthenia Gravis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.10 CSL
        2.10.1 Business Overview
        2.10.2 Myasthenia Gravis Drugs Type and Applications
            2.10.2.1 Product A
            2.10.2.2 Product B
        2.10.3 CSL Myasthenia Gravis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.11 Curavac
        2.11.1 Business Overview
        2.11.2 Myasthenia Gravis Drugs Type and Applications
            2.11.2.1 Product A
            2.11.2.2 Product B
        2.11.3 Curavac Myasthenia Gravis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.12 Cytokinetics
        2.12.1 Business Overview
        2.12.2 Myasthenia Gravis Drugs Type and Applications
            2.12.2.1 Product A
            2.12.2.2 Product B
        2.12.3 Cytokinetics Myasthenia Gravis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.13 Galencia
        2.13.1 Business Overview
        2.13.2 Myasthenia Gravis Drugs Type and Applications
            2.13.2.1 Product A
            2.13.2.2 Product B
        2.13.3 Galencia Myasthenia Gravis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.14 GlaxoSmithKline
        2.14.1 Business Overview
        2.14.2 Myasthenia Gravis Drugs Type and Applications
            2.14.2.1 Product A
            2.14.2.2 Product B
        2.14.3 GlaxoSmithKline Myasthenia Gravis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.15 Lupin Pharmaceuticals
        2.15.1 Business Overview
        2.15.2 Myasthenia Gravis Drugs Type and Applications
            2.15.2.1 Product A
            2.15.2.2 Product B
        2.15.3 Lupin Pharmaceuticals Myasthenia Gravis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.16 Mitsubishi Tanabe Pharma
        2.16.1 Business Overview
        2.16.2 Myasthenia Gravis Drugs Type and Applications
            2.16.2.1 Product A
            2.16.2.2 Product B
        2.16.3 Mitsubishi Tanabe Pharma Myasthenia Gravis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Myasthenia Gravis Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
    3.1 Global Myasthenia Gravis Drugs Sales and Market Share by Manufacturer (2017-2018)
    3.2 Global Myasthenia Gravis Drugs Revenue and Market Share by Manufacturer (2017-2018)
    3.3 Market Concentration Rate
        3.3.1 Top 3 Myasthenia Gravis Drugs Manufacturer Market Share in 2018
        3.3.2 Top 6 Myasthenia Gravis Drugs Manufacturer Market Share in 2018
    3.4 Market Competition Trend
4 Global Myasthenia Gravis Drugs Market Analysis by Regions
    4.1 Global Myasthenia Gravis Drugs Sales, Revenue and Market Share by Regions
        4.1.1 Global Myasthenia Gravis Drugs Sales and Market Share by Regions (2014-2019)
        4.1.2 Global Myasthenia Gravis Drugs Revenue and Market Share by Regions (2014-2019)
    4.2 North America Myasthenia Gravis Drugs  Sales and Growth Rate (2014-2019)
    4.3 Europe Myasthenia Gravis Drugs  Sales and Growth Rate (2014-2019)
    4.4 Asia-Pacific Myasthenia Gravis Drugs  Sales and Growth Rate (2014-2019)
    4.5 South America Myasthenia Gravis Drugs  Sales and Growth Rate (2014-2019)
    4.6 Middle East and Africa Myasthenia Gravis Drugs  Sales and Growth Rate (2014-2019)
5 North America Myasthenia Gravis Drugs by Country
    5.1 North America Myasthenia Gravis Drugs Sales, Revenue and Market Share by Country
        5.1.1 North America Myasthenia Gravis Drugs Sales and Market Share by Country (2014-2019)
        5.1.2 North America Myasthenia Gravis Drugs Revenue and Market Share by Country (2014-2019)
    5.2 United States Myasthenia Gravis Drugs Sales and Growth Rate (2014-2019)
    5.3 Canada Myasthenia Gravis Drugs Sales and Growth Rate (2014-2019)
    5.4 Mexico Myasthenia Gravis Drugs Sales and Growth Rate (2014-2019)
6 Europe Myasthenia Gravis Drugs by Country
    6.1 Europe Myasthenia Gravis Drugs Sales, Revenue and Market Share by Country
        6.1.1 Europe Myasthenia Gravis Drugs Sales and Market Share by Country (2014-2019)
        6.1.2 Europe Myasthenia Gravis Drugs Revenue and Market Share by Country (2014-2019)
    6.2 Germany Myasthenia Gravis Drugs Sales and Growth Rate (2014-2019)
    6.3 UK Myasthenia Gravis Drugs Sales and Growth Rate (2014-2019)
    6.4 France Myasthenia Gravis Drugs Sales and Growth Rate (2014-2019)
    6.5 Russia Myasthenia Gravis Drugs Sales and Growth Rate (2014-2019)
    6.6 Italy Myasthenia Gravis Drugs Sales and Growth Rate (2014-2019)
7 Asia-Pacific Myasthenia Gravis Drugs by Country
    7.1 Asia-Pacific Myasthenia Gravis Drugs Sales, Revenue and Market Share by Country
        7.1.1 Asia-Pacific Myasthenia Gravis Drugs Sales and Market Share by Country (2014-2019)
        7.1.2 Asia-Pacific Myasthenia Gravis Drugs Revenue and Market Share by Country (2014-2019)
    7.2 China Myasthenia Gravis Drugs Sales and Growth Rate (2014-2019)
    7.3 Japan Myasthenia Gravis Drugs Sales and Growth Rate (2014-2019)
    7.4 Korea Myasthenia Gravis Drugs Sales and Growth Rate (2014-2019)
    7.5 India Myasthenia Gravis Drugs Sales and Growth Rate (2014-2019)
    7.6 Southeast Asia Myasthenia Gravis Drugs Sales and Growth Rate (2014-2019)
8 South America Myasthenia Gravis Drugs by Country
    8.1 South America Myasthenia Gravis Drugs Sales, Revenue and Market Share by Country
        8.1.1 South America Myasthenia Gravis Drugs Sales and Market Share by Country (2014-2019)
        8.1.2 South America Myasthenia Gravis Drugs Revenue and Market Share by Country (2014-2019)
    8.2 Brazil Myasthenia Gravis Drugs Sales and Growth Rate (2014-2019)
    8.3 Argentina Myasthenia Gravis Drugs Sales and Growth Rate (2014-2019)
    8.4 Colombia Myasthenia Gravis Drugs Sales and Growth Rate (2014-2019)
9 Middle East and Africa Myasthenia Gravis Drugs by Countries
    9.1 Middle East and Africa Myasthenia Gravis Drugs Sales, Revenue and Market Share by Country
        9.1.1 Middle East and Africa Myasthenia Gravis Drugs Sales and Market Share by Country (2014-2019)
        9.1.2 Middle East and Africa Myasthenia Gravis Drugs Revenue and Market Share by Country (2014-2019)
    9.2 Saudi Arabia Myasthenia Gravis Drugs Sales and Growth Rate (2014-2019)
    9.3 Turkey Myasthenia Gravis Drugs Sales and Growth Rate (2014-2019)
    9.4 Egypt Myasthenia Gravis Drugs Sales and Growth Rate (2014-2019)
    9.5 Nigeria Myasthenia Gravis Drugs Sales and Growth Rate (2014-2019)
    9.6 South Africa Myasthenia Gravis Drugs Sales and Growth Rate (2014-2019)
10 Global Myasthenia Gravis Drugs Market Segment by Type
    10.1 Global Myasthenia Gravis Drugs Sales, Revenue and Market Share by Type (2014-2019)
        10.1.1 Global Myasthenia Gravis Drugs Sales and Market Share by Type (2014-2019)
        10.1.2 Global Myasthenia Gravis Drugs Revenue and Market Share by Type (2014-2019)
    10.2 Anticholinesterases Sales Growth and Price
        10.2.1 Global Anticholinesterases Sales Growth (2014-2019)
        10.2.2 Global Anticholinesterases Price (2014-2019)
    10.3 Immunosuppressants Sales Growth and Price
        10.3.1 Global Immunosuppressants Sales Growth (2014-2019)
        10.3.2 Global Immunosuppressants Price (2014-2019)
    10.4 Intravenous Immune Globulins Sales Growth and Price
        10.4.1 Global Intravenous Immune Globulins Sales Growth (2014-2019)
        10.4.2 Global Intravenous Immune Globulins Price (2014-2019)
11 Global Myasthenia Gravis Drugs Market Segment by Application
    11.1 Global Myasthenia Gravis Drugs Sales Market Share by Application (2014-2019)
    11.2 Hospitals Sales Growth (2014-2019)
    11.3 Clinics Sales Growth (2014-2019)
12 Myasthenia Gravis Drugs Market Forecast (2019-2024)
    12.1 Global Myasthenia Gravis Drugs Sales, Revenue and Growth Rate (2019-2024)
    12.2 Myasthenia Gravis Drugs Market Forecast by Regions (2019-2024)
        12.2.1 North America Myasthenia Gravis Drugs Market Forecast (2019-2024)
        12.2.2 Europe Myasthenia Gravis Drugs Market Forecast (2019-2024)
        12.2.3 Asia-Pacific Myasthenia Gravis Drugs Market Forecast (2019-2024)
        12.2.4 South America Myasthenia Gravis Drugs Market Forecast (2019-2024)
        12.2.5 Middle East and Africa Myasthenia Gravis Drugs Market Forecast (2019-2024)
    12.3 Myasthenia Gravis Drugs Market Forecast by Type (2019-2024)
        12.3.1 Global Myasthenia Gravis Drugs Sales Forecast by Type (2019-2024)
        12.3.2 Global Myasthenia Gravis Drugs Market Share Forecast by Type (2019-2024)
    12.4 Myasthenia Gravis Drugs Market Forecast by Application (2019-2024)
        12.4.1 Global Myasthenia Gravis Drugs Sales Forecast by Application (2019-2024)
        12.4.2 Global Myasthenia Gravis Drugs Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
    13.1 Sales Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
        13.1.3 Marketing Channel Future Trend
    13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
    15.1 Methodology
    15.2 Data Source

Related Categories
Pharmaceuticals
Related Reports
Global Tigecycline Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2027

The report on the Global Tigecycline Market gives an estimation of the development of the market based on historical studies and also provides forecasts  read more..


Global Risperidone Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

The Global Risperidone Market Report is equipped with market data from 2015 to 2025. The report gives a market overview covering key drivers and risks  read more..


Global Caffeine Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2027

The report on the Global Caffeine Market gives an estimation of the development of the market based on historical studies and also provides forecasts on  read more..


Global Rabies Vaccine Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2027

The report on the Global Rabies Vaccine Market gives an estimation of the development of the market based on historical studies and also provides  read more..


Global Radiopharmaceuticals Market Insights, Forecast to 2025

Radiopharmaceuticals Market Research Report offered by DecisionDatabases.com provides a detailed study on the industrial development of the market under  read more..


Global Neurorehabilitation System Market Research Report

The report on the Global Neurorehabilitation System Market gives an estimation of the development of the market based on historical studies and also  read more..


Global Molecular Biology Kits And Reagents Market Research Report

The report on the Global Molecular Biology Kits And Reagents Market gives an estimation of the development of the market based on historical studies and  read more..


Global High Acuity Care Information Systems Market Research Report

The report on the Global High Acuity Care Information Systems Market gives an estimation of the development of the market based on historical studies and  read more..


Global Regenerative Medicine Market Research Report

The global regenerative medicine market was estimated to be at ~$4.5 billion in 2013.   A number of factors such as increasing bone related  read more..


Global Skin Cancer Diagnostics Market Research Report

The report on the Global Skin Cancer Diagnostics Market gives an estimation of the development of the market based on historical studies and also  read more..